Research

Hormonal

Discontinuation of GLP-1 medications leads to rapid weight regain (up to two-thirds of prior loss) and worsening cardiometabolic health, disproportionately affecting underserved communities.

Stopping GLP-1 medication often leads to regaining up to two-thirds of the weight lost and worsening health. It is crucial to have a sustainable plan for medication access or transition to maintain long-term health.

GoodRefutesHIGH confidence
rapid weight gain of up to 2 thirds of prior weight loss, as well as worsening cardiometabolic health, occurs once GLP-1 RA treatment is stopped.
Mary T. Imboden · American Journal of Health Promotion · 2025

Why this rating

Cites multiple studies (refs 31-35) on discontinuation rates and effects.

Source

Knowing Well, Being Well: well-being born of understanding: Access to GLP-1s: Where Do Employers Fit in?

Mary T. Imboden · American Journal of Health Promotion · 2025

DOI 10.1177/08901171251335507

narrative_reviewCited 3×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →